Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Behring Diagnostics Establishes Legal Entities in Several European Countries.


FRANKFURT, Germany--(BW HealthWire)--Jan. 21, 1997--Behring Diagnostics GmbH, today announced the creation of several legal entities in the company's designated Europe Region II/Africa Region. These entities are or will become wholly-owned subsidiaries of the newly established Behring Diagnostics GmbH. Behring Diagnostics GmbH is the new management company for the diagnostics business within the Hoechst Group's life sciences business. Hoechst Marion Roussel, Behring Diagnostics, Hoechst Roussel Vet, and AgrEvo make up the Hoechst Group's life sciences business.

Heinz Heuser is head of Europe Region II/Africa for Behring Diagnostics GmbH. In this region, three new legal entities are now established: Behring Diagnostika Hellas A.B.E.E., based in Athens, Greece, and managed by Frank Nuhs; Behring Diagnostika Polska GmbH, based in Warsaw, and managed by Peter Szulc and Waldemar Dobrzynski, and Behring Diagnostics Finland Oy/Ab, based in Helsinki, and managed by Anja Terhonen. Countries in this region include Austria, Italy, Denmark, Finland, East Africa, Finland, Greece, Ireland, Norway, Poland, South Africa South Africa, Afrikaans Suid-Afrika, officially Republic of South Africa, republic (2005 est. pop. 44,344,000), 471,442 sq mi (1,221,037 sq km), S Africa. , Sweden, Switzerland, Iran, Turkey, United Kingdom, and other major Eastern European countries.

Uwe Bicker bick·er  
intr.v. bick·ered, bick·er·ing, bick·ers
1. To engage in a petty, bad-tempered quarrel; squabble. See Synonyms at argue.

2.
, MD, PhD, chairman of Behring Diagnostics GmbH, said, "Restructuring of the new organization is aggressively underway. The establishment of the legal entities is a major step in streamlining the company to assure more effective management on a global level."

With headquarters in Frankfurt, Germany, Behring Diagnostics GmbH, manufactures and markets in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment.

in vi·tro
adj.
In an artificial environment outside a living organism.
 diagnostic systems used by healthcare professionals in hospitals and laboratories throughout the world. The company has five business lines: plasma proteins, coagulation coagulation (kōăg'ylā`shən), the collecting into a mass of minute particles of a solid dispersed throughout a liquid (a sol), usually followed by the precipitation or  and microbiology, based in Marburg, Germany; the OPUS(R) business line, located in Westwood, Massachusetts Westwood is a town in Norfolk County, Massachusetts, United States. The population was 14,117 at the 2000 census. History
Westwood was first settled in 1640 and was part of the town of Dedham (it was originally called 'West Dedham') until it was officially incorporated
; and the Syva(R) business line, based in San Jose, California San Jose (IPA: /ˌsænhoʊˈzeɪ/) is the third-largest city in California, and the tenth-largest in the United States. It is the county seat of Santa Clara County. . Behring Diagnostics acquired the former Syva Company in 1995. Behring Diagnostics had consolidated net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
 of DM 1.027 billion, in 1995, and employs approximately 3,000 worldwide. -0-

Note to Editors: OPUS and Syva are registered trademarks of Behring Diagnostics GmbH.

CONTACT: Behring Diagnostics

Charlotte Dexter, +44 (171) 384-3390 or

+1 (800)223-7982, box 9778
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 21, 1997
Words:334
Previous Article:Citicorp fourth quarter net income increased 9% to $987 million on 14% revenue gain; earnings per common share rose 15% to $1.97; return on common...
Next Article:Chancellor Corporation Announces the Signing of a $150 Million Contract with K-MART Corporation.
Topics:



Related Articles
BEHRING DIAGNOSTICS COMPLETES ACQUISITION OF SYVA CO.; Senior Management Named for Global Operations.
Behring Diagnostics' Cardiac Marker Assay Receives US Marketing Clearance; New Cardiac Troponin I Assay will Provide Results in 22 Minutes.
Behring Diagnostics GmbH announces new structure of its global diagnostics business.
Behring Diagnostics Names New General Manager in France.
Diagnostic Products and Dade Behring Alliance Awarded Novation Immunochemistry Contract.
ZymeTx and Dade Behring Sign Nationwide Distribution Agreement for ZstatFlu.
LAWSUIT HOLDS UP SEAHAWKS' DEALING.
TICKET SEEKERS WILL HAVE TO WAIT.
EDITORIAL\Don't fumble it away\L.A. officials must act quickly on latest opportunity for pro\football.
SEAHAWKS OWNER SUED BY STATE OF WASHINGTON.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles